Sunshine Act: shedding light on inaccurate disclosures at a gynecologic annual meeting

American Journal of Obstetrics and Gynecology

Volumn 215, Issue 5, 2016, Pages 661.e1-661.e7

  Thompson, Jennifer C ^a   Volpe, Katherine A ^a   Bridgewater, Lindsay K ^a   Qeadan, Fares ^b   Dunivan, Gena C ^a   Komesu, Yuko M ^a   Cichowski, Sara B ^a   Jeppson, Peter C ^a   Rogers, Rebecca G ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

financial disclosures; Open Payments database; Sunshine Act

Indexed keywords

ABSTRACT REPORT; ARTICLE; DATA BASE; FEMALE; GYNECOLOGY; HEALTH CARE POLICY; HUMAN; MALE; MEDICAID; MEDICAL FEE; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICARE; PHYSICIAN; PRIORITY JOURNAL; SELF DISCLOSURE; CONFLICT OF INTEREST; DOCUMENTATION; DRUG INDUSTRY; ECONOMICS; ETHICS; FACTUAL DATABASE; INTERPERSONAL COMMUNICATION; LEGISLATION AND JURISPRUDENCE; ORGANIZATION; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ABSTRACTING AND INDEXING AS TOPIC; CONFLICT OF INTEREST; CONGRESSES AS TOPIC; DATABASES, FACTUAL; DISCLOSURE; DRUG INDUSTRY; FEMALE; GYNECOLOGY; HUMANS; MALE; MEDICAID; MEDICARE; PHYSICIANS; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84994404414     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.06.015     Document Type: Article

References (17)

1. 1 Bekelman, J.E., Li, Y., Gross, C.P., Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289 (2003), 454–465.
2. 2 Brichacek A, Sellers, LJ. Flexing their budgets: big pharma spend trends. Pharmaceutical Executive 2001:78-86.
3. 3 Campbell, E.G., Gruen, R.L., Mountford, J., Miller, L.G., Cleary, P.D., Blumenthal, D., A national survey of physician-industry relationships. N Engl J Med 356 (2007), 1742–1750.
4. 4 Chren, M.M., Landefeld, C.S., Physicians’ behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 271 (1994), 684–689.
5. 5 Lurie, N., Rich, E.C., Simpson, D.E., et al. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med 5 (1990), 240–243.
6. 6 Bower, A.D., Burkett, G.L., Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices. J Fam Pract 24 (1987), 612–616.
7. 7 Peay, M.Y., Peay, E.R., The role of commercial sources in the adoption of a new drug. Soc Sci Med 26 (1988), 1183–1189.
8. 8 Orlowski, J.P., Wateska, L., The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch. Chest 102 (1992), 270–273.
9. 9 Davidson, R.A., Source of funding and outcome of clinical trials. J Gen Intern Med 1 (1986), 155–158.
10. 10 Steinman, M.A., Shlipak, M.G., McPhee, S.J., Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 110 (2001), 551–557.
11. 11 Madhavan, S., Amonkar, M.M., Elliott, D., Burke, K., Gore, P., The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians. J Clin Pharm Ther 22 (1997), 207–215.
12. 12 Gibbons, R.V., Landry, F.J., Blouch, D.L., et al. A comparison of physicians’ and patients’ attitudes toward pharmaceutical industry gifts. J Gen Intern Med 13 (1998), 151–154.
13. 13 Banks, J.W. 3rd, Mainous, A.G. 3rd, Attitudes of medical school faculty toward gifts from the pharmaceutical industry. Acad Med 67 (1992), 610–612.
14. 14 Transparency reports and reporting of physician ownership of investment interests: final rule, Department of Health and Human Services. Fed Regist 78 (2013), 9458–9528.
15. 15 Harris, P.A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., Conde, J.G., Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42 (2009), 377–381.
16. 16 Okike, K., Kocher, M.S., Wei, E.X., Mehlman, C.T., Bhandari, M., Accuracy of conflict-of-interest disclosures reported by physicians. N Engl J Med 361 (2009), 1466–1474.
17. 17 Ramm, O., Brubaker, L., Conflicts-of-interest disclosures at the 2010 AUGS Scientific Meeting. Female Pelvic Med Reconstr Surg 18 (2012), 79–81.